Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H31NO4S |
Molecular Weight | 429.572 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC[C@H](O)C1=CC=C(C=C1)N2[C@@H](CCCC3=CC=C(S3)C(O)=O)CCC2=O
InChI
InChIKey=WXWCSPFQIXPFLD-RXVVDRJESA-N
InChI=1S/C24H31NO4S/c1-2-3-4-8-21(26)17-9-11-19(12-10-17)25-18(13-16-23(25)27)6-5-7-20-14-15-22(30-20)24(28)29/h9-12,14-15,18,21,26H,2-8,13,16H2,1H3,(H,28,29)/t18-,21-/m0/s1
Molecular Formula | C24H31NO4S |
Molecular Weight | 429.572 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Originator
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://patents.google.com/patent/WO2014078434A1
Aganepag (Compound 3) is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:16:10 GMT 2023
by
admin
on
Fri Dec 15 19:16:10 GMT 2023
|
Record UNII |
ODT7ZEW9O7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
YY-24
Created by
admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
|
PRIMARY | |||
|
ODT7ZEW9O7
Created by
admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
|
PRIMARY | |||
|
C174796
Created by
admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
|
PRIMARY | |||
|
300000034070
Created by
admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
|
PRIMARY | |||
|
9400
Created by
admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
|
PRIMARY | |||
|
24759922
Created by
admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
|
PRIMARY | |||
|
910562-18-4
Created by
admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103861
Created by
admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|